Purified anti-Tau Phospho Ser396 Antibody - PHF-13,BioLegend,829001

The PHF-13 antibody reacts with human tau phosphorylated at Ser 396.

Host

Mouse

Reactivity

Human

Application

IHC-P -Quality testedWB -Reported in the literature, not verified in house

Platform ID

BAB953877765

BioLegend

Headquarters

8999 BioLegend Way San Diego, CA 92121 United States

Contact

Tel: 1-858-455-9588
Fax: +49 (4131) 7023913

Email:

Product Specifications
Scientific Background

Specifications

NamePurified anti-Tau Phospho Ser396 Antibody - PHF-13
Cat. No.829001
HostMouse
RRIDAB_2728540 (BioLegend Cat. No. 829003)AB_2564925 (BioLegend Cat. No. 829001)
IsotypeMouse IgG2b, κ
ReactivityHuman
ApplicationIHC-P -Quality testedWB -Reported in the literature, not verified in house
ClonalityMonoclonal
Clone NumberPHF-13
Concentration1 mg/mL
TargetTau Phospho Ser396
ImmunogenThe PHF-13 antibody was raised using PHF-tau preparations from human brain.
PurityThe antibody was purified by affinity chromatography.
FormulationPhosphate-buffered solution; no preservatives or carrier proteins.
StorageThis antibody should be handled aseptically as it is free of preservatives such as Sodium Azide. Store this antibody undiluted between 2°C and 8°C. Please note the storage condition for this antibody has been changed from -20°C to between 2°C and 8°C. You can also check the vial label orCoAto find the proper storage conditions.
Regulatory StatusResearch Use Only

Scientific Background

Paired helical filaments (PHFs) are the major building blocks of neurofibrillary lesions in Alzheimer's disease brains and are composed of hyperphosphorylated tau protein. Predominantly expressed in axons, alternatively spliced forms of tau comprise a family of microtubule-associated proteins that normally promote and stabilize the assembly of microtubules. PHF-tau differs from normal tau by its abnormal hyperphosphorylation, which results in decreased binding of tau to microtubules. The decreased affinity of PHF-tau for microtubules, coupled with reduced levels of normal tau, destabilizes microtubules leading to an impairment of axonal transport, neuronal death and the aggregation of PHFs. Therefore, hyperphosphorylation of tau is believed to be a key event in the pathogenesis of Alzheimer's disease.

Category Paths

Request a product

Please provide the required information below so that we can quickly source your products.